CRUK Stem Cell Biology Group, CRUK Manchester Institute, 555 Wilmslow Road, Manchester M20 4GJ, UK.
Department of Molecular and Cell Biology, University of Leicester, Lancaster Road, Leicester LE1 7RH, UK.
Stem Cell Reports. 2018 Apr 10;10(4):1369-1383. doi: 10.1016/j.stemcr.2018.03.011.
The first hematopoietic stem and progenitor cells are generated during development from hemogenic endothelium (HE) through trans-differentiation. The molecular mechanisms underlying this endothelial-to-hematopoietic transition (EHT) remain poorly understood. Here, we explored the role of the epigenetic regulators HDAC1 and HDAC2 in the emergence of these first blood cells in vitro and in vivo. Loss of either of these epigenetic silencers through conditional genetic deletion reduced hematopoietic transition from HE, while combined deletion was incompatible with blood generation. We investigated the molecular basis of HDAC1 and HDAC2 requirement and identified TGF-β signaling as one of the pathways controlled by HDAC1 and HDAC2. Accordingly, we experimentally demonstrated that activation of this pathway in HE cells reinforces hematopoietic development. Altogether, our results establish that HDAC1 and HDAC2 modulate TGF-β signaling and suggest that stimulation of this pathway in HE cells would be beneficial for production of hematopoietic cells for regenerative therapies.
造血干细胞和祖细胞最初是在发育过程中由造血内皮细胞(HE)通过转分化产生的。这种内皮细胞向造血细胞过渡(EHT)的分子机制仍知之甚少。在这里,我们研究了表观遗传调节剂 HDAC1 和 HDAC2 在体外和体内这些最初血细胞出现中的作用。通过条件性基因缺失去除这些表观遗传沉默因子中的任何一个都会减少 HE 的造血转化,而联合缺失则与血液生成不相容。我们研究了 HDAC1 和 HDAC2 需求的分子基础,并确定 TGF-β 信号是 HDAC1 和 HDAC2 控制的途径之一。因此,我们通过实验证明,在 HE 细胞中激活该途径会增强造血发育。总之,我们的研究结果表明,HDAC1 和 HDAC2 调节 TGF-β 信号,并提示刺激 HE 细胞中的该途径将有益于再生疗法中造血细胞的生成。